Howard J. Federoff, M.D., Ph.D.

Vice Chancellor, Health Affairs
Chief Executive Officer, UC Irvine Health System

Howard J. Federoff, M.D., Ph.D.
Howard J. Federoff, M.D., Ph.D.

Social Links:

Dr. Howard Federoff, M.D., Ph.D., became CEO of UCI Health System in January 2016, after previously serving as the Dean of the School of Medicine. Dr. Federoff’s current dual role of Vice Chancellor for Health Affairs and the CEO of UCI Health System, ensures alignment between both clinical expansion and the expansion of our academic and research missions. As Vice Chancellor for Health Affairs, Dr. Federoff has responsibility for the clinical, medical educational, and research missions. As CEO of UC Irvine Health System, Dr. Federoff oversees the administration of clinical locations, UC Irvine Medical Center, the Chao Family Comprehensive Cancer Center, and UC Irvine Health’s numerous primary and specialty care outpatient centers. A nationally renowned clinical and research leader and a groundbreaking investigator for neurological disorders, Dr. Federoff’s research led to a new gene therapeutic trial in Parkinson’s disease, in predicting the onset of Alzheimer’s disease. Dr. Federoff has an academic appointment in the department of Neurology. He has published greater than 250 peer reviewed and invited articles and serves as a reviewer for many journals, and currently serves on the editorial boards of five journals. Dr. Federoff served as Chair of the NIH Recombinant DNA Advisory Committee from 2007-2010. He Chaired the Gene Therapy Resource Program for NHLBI (2010-2016), was President for the American Society for Neural Therapy and Repair (2012-2013) and President of the American Society for Experimental Neurotherapeutics (2014-2016). He is chair-elect of the Association of Academic Health Centers (AAHC) Board. Dr. Federoff is an elected Fellow of the American Association for the Advancement of Science and the National Academy of Inventors